Sort   by:  
 Page size 
UnknownEfficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials.
Not available
S-EPMC4534523 | biostudies-literature
TranscriptomicsMicroarray of A375, MDAMB468, SUM52PE, SKBR3, T47D, HCC827 and MKN45 cancer cell lines treated with rapamycin compared to DMSO-treated control
Comparison of gene expression in cancer cell lines treated with rapamycin for 24h compared to DMSO
ORGANISM(S): Homo sapiens 
2020-07-31 | E-MTAB-8727 | biostudies-arrayexpress
TranscriptomicsRNA-seq of human breast cancer cell line MCF-7 treated for 24h with rapamycin or DMSO
Investigation of differential pre-mRNA splicing in breast cancer cell line MCF-7 treated with rapamycin compared to vehicle DMSO that are overexpressing TRIB3
ORGANISM(S): Homo sapiens 
2020-07-31 | E-MTAB-8726 | biostudies-arrayexpress
TranscriptomicsTranscription profiling by array of breast cancer distant metastasis based on outcome over time and identification of pathway activities of late relapse
Previous reports have described the use of microarrays to assess the molecular classification of human breast cancers and defined new subgroups based on gene expression that are relevant to patient management through their ability to predict metastatic relapse and survival relapse. However, differen...
ORGANISM(S): Homo sapiens 
2013-08-01 | E-MTAB-949 | biostudies-arrayexpress
TranscriptomicsAtra effect on ERBB2 and RARA-coamplified SKBR-3 cells.
RNA was extracted with Rneasy Micro Kit (Qiagen, France) from SKBR3 cells treated with 1 uM ATRA. The quantity and purity of the extracted RNA was evaluated using a NanoDropTM spectrophotometer and its integrity measured using an Agilent BioanalyzerTM. For microarray hybridizations, 500 ng of total ...
ORGANISM(S): Homo sapiens 
2012-03-02 | E-MTAB-1013 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of human malignant or benign breast cancer tumors to identify genes that present a differential expression between the two types of lesion
Background. Although gene expression arrays have been used to generate molecular predictors of relapse and drug sensitivity in breast cancer, no large study describes genes and exons differentially expressed between breast cancer and benign lesions.

Methods. One hundred and sixty-five tumour...
ORGANISM(S): Homo sapiens 
2009-12-30 | E-TABM-609 | biostudies-arrayexpress
Sort   by:  
 Page size